Frontlight ResearchEarly access
Trial site
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Ministerstwa Spraw Wewnetrznych I Administracji Z Warminsko-Mazurskim Centrum Onkologii W Olsztynie
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Diffuse large B-cell lymphoma2 trials
- Acute myeloid leukaemia1 trial
- Endometrial cancer1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 37 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC2 trials
- Bristol-Myers Squibb1 trial
- Incyte Corporation1 trial
- Medical University Of Lodz1 trial
- Merck Sharp & Dohme Corp.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Completed
Phase 3 study of SBRT ± pembrolizumab for participants with unresectable Stage I or II NSCLC
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026